Cipla gets eight observations after FDA inspection at Bengaluru plant
The inspection, which took place from November 7 to November 13, concluded with the issuance of Form 483, a document outlining conditions the regulator believes may need improvement for compliance with manufacturing practices.

What's Your Reaction?






